Hasan Ongun Onaran

Hasan Ongun Onaran

Auto-generated profile, based on publicly available information

Hasan Ongun Onaran

Ankara University Faculty of Medicine

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2022 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
PKPeter Kolb
Peter Kolb
TKTerry Kenakin
Terry Kenakin
SASteve Alexander
Steve Alexander
MBMarcel Bermudez
Marcel Bermudez
LBLaura M. Bohn
Laura M. Bohn
DGDavid E. Gloriam
David E. Gloriam
G protein-coupled receptors modulate a plethora of physiological processes and mediate the effects of one-third of FDA-approved drugs. Depending on which ligand activates a receptor, it can engage different intracellular transducers. This ‘biased signaling’ paradigm requires that we now characterize physiological signaling not just by receptors but by ligand-receptor pairs. Ligands eliciting biased signaling may constitute better drugs with higher efficacy and fewer adverse effects. However, ligand bias is very complex, making reproducibility and description challenging. Here, we provide guidelines and terminology for any scientists to design and report ligand bias experiments. The guidelines will aid consistency and clarity, as the basic receptor research and drug discovery communities continue to advance our understanding and exploitation of ligand bias. Scientific insight, biosensors, and analytical methods are still evolving and should benefit from and contribute to the implementation of the guidelines, together improving translation from in vitro to disease-relevant in vivo models.

22 February 1993 in FEBS Letters
Verified
Journal Article
Closed access
LCLeonid V. Chernomordik
Leonid V. Chernomordik
SVSteven S. Vogel
Steven S. Vogel
ASAleksander Sokoloff
Aleksander Sokoloff
HOH.ONgun Onaran
H.ONgun Onaran
ELEvgenia A. Leikina
Evgenia A. Leikina
JZJoshua Zimmerberg
Joshua Zimmerberg

1 May 1997 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HOH. Ongun Onaran
H. Ongun Onaran
TCTommaso Costa
Tommaso Costa

14 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HOH. Ongun Onaran
H. Ongun Onaran
CACaterina Ambrosio
Caterina Ambrosio
ÖUÖzlem Uğur
Özlem Uğur
EKErzsebet Madaras Koncz
Erzsebet Madaras Koncz
MGMaria Cristina Grò
Maria Cristina Grò
TCTommaso Costa
Tommaso Costa
Discovering biased agonists requires a method that can reliably distinguish the bias in signalling due to unbalanced activation of diverse transduction proteins from that of differential amplification inherent to the system being studied, which invariably results from the non-linear nature of biological signalling networks and their measurement. We have systematically compared the performance of seven methods of bias diagnostics, all of which are based on the analysis of concentration-response curves of ligands according to classical receptor theory. We computed bias factors for a number of β-adrenergic agonists by comparing BRET assays of receptor-transducer interactions with Gs, Gi and arrestin. Using the same ligands, we also compared responses at signalling steps originated from the same receptor-transducer interaction, among which no biased efficacy is theoretically possible. In either case, we found a high level of false positive results and a general lack of correlation among methods. Altogether this analysis shows that all tested methods, including some of the most widely used in the literature, fail to distinguish true ligand bias from “system bias” with confidence. We also propose two novel semi quantitative methods of bias diagnostics that appear to be more robust and reliable than currently available strategies.

1 February 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AKAli I. Kaya
Ali I. Kaya
HOH. Ongun Onaran
H. Ongun Onaran
Gulnihal OzcanGulnihal Ozcan
Gulnihal Ozcan
CACaterina Ambrosio
Caterina Ambrosio
TCTommaso Costa
Tommaso Costa
ÖUÖzlem Uğur
Özlem Uğur
Activation of β(2)-adrenegic receptor (β(2)-AR) leads to an increase in intracellular cAMP and activation of ERK. These two signals are activated by the interaction of the receptor with different transducer partners. We showed that the intrinsic activities of β(2)-AR ligands for stimulating cAMP production and ERK phosphorylation responses in HEK-293 cells were not correlated. The lack of correlation resulted mainly from the discrepancy between the intrinsic activities of two groups of ligands for these two responses: The first group consisted of clenbuterol, cimaterol, procaterol, and terbutaline which acted as full agonists for cAMP production but displayed very weak effect on ERK phosphorylation. The second group comprised adrenaline and noradrenaline which displayed higher intrinsic activity for the ERK phosphorylation than for the cAMP response. Thus, both groups behaved as functionally selective ligands. The functional selectivity of the first group was observable only in adherent cells when confluence was approximately 100%. When cell-cell contact was minimized either by decreasing the density of the adherent cells or by bringing the cells into suspension, the first group of ligands gained the ability to stimulate ERK phosphorylation without a change in their effect on cAMP production. In contrast, selectivity of the second group was independent of the adherence state of the cells. Our results show that the inherent "bias" of ligands in coupling a G protein-coupled receptor to different transducers may not always be revealed as functional selectivity when there is a "cross-talk" between the signaling pathways activated by the same receptor.

1 December 2014 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
HOH. Ongun Onaran
H. Ongun Onaran
SRSudarshan Rajagopal
Sudarshan Rajagopal
TCTommaso Costa
Tommaso Costa